Dr. Reddy's Laboratories Limited (DRREDDY) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.

Total Revenue Chart for Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited (DRREDDY) revenue for FY2026 was INR 335.9B, a 3.2% change from FY2025. Dr. Reddy's Laboratories Limited's revenue grew from INR 10.9B in 2001 to INR 335.9B in 2026 (2972.1% over 25 years). Earnings per share grew from INR 25.17 in 2014 to INR 67.79 in 2025 (169.3%). Revenue compound annual growth rate: 5-year CAGR of 12.1%, 10-year CAGR of 8.1%, 20-year CAGR of 14.0%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.